Emcure Pharma IPO: Here's what GMP signals ahead of opening for subscription
The shares of Emcure Pharma IPO is trading at a premium of ₹255 in the grey market premium (GMP) on Saturday, June 29, just days before the issue opens for subscription, according to investorgain.com.
DNA News Desk
0
2
The shares of Emcure Pharma IPO is trading at a premium of ₹255 in the grey market premium (GMP) on Saturday, June 29, just days before the issue opens for subscription, according to investorgain.com.
